collection
https://read.qxmd.com/read/23859663/atypical-antipsychotics-in-the-treatment-of-delirium
#21
REVIEW
Hee Ryung Wang, Young Sup Woo, Won-Myong Bahk
The aim of this study was to review the efficacy and safety of atypical antipsychotics, comparing within class, placebo, or compared to another active treatment for delirium. A literature search was conducted using PubMed, EMBASE, and the Cochrane database (1 January 1990-5 November 2012). Selection criteria for review were prospective, controlled studies (comparison studies), using validated delirium rating scales as outcome measures. A total of six prospective, randomized controlled studies were included in the review...
July 2013: Psychiatry and Clinical Neurosciences
https://read.qxmd.com/read/12970516/efficacy-and-tolerability-of-donepezil-in-vascular-dementia-positive-results-of-a-24-week-multicenter-international-randomized-placebo-controlled-clinical-trial
#22
RANDOMIZED CONTROLLED TRIAL
Sandra Black, Gustavo C Román, David S Geldmacher, Stephen Salloway, Jane Hecker, Alistair Burns, Carlos Perdomo, Dinesh Kumar, Raymond Pratt
BACKGROUND AND PURPOSE: Clinical observations suggest that patients with vascular dementia (VaD) may benefit from treatment with cholinesterase inhibitors. This study evaluated the efficacy and safety of donepezil for relieving symptoms of dementia in VaD. METHODS: Patients (n=603; mean age, 73.9 years; 55.2% men) with probable (70.5%) or possible (29.5%) VaD, according to criteria of the National Institute of Neurological Disorders and Stroke (NINDS) and the Association Internationale pour la Recherche et l'Enseignement en Neurosciences (AIREN), were randomized to 24 weeks of treatment with donepezil 5 mg/d (n=198), donepezil 10 mg/d (5 mg/d for first 28 days; n=206), or placebo (n=199)...
October 2003: Stroke; a Journal of Cerebral Circulation
https://read.qxmd.com/read/22783304/use-of-antiarrhythmic-drugs-in-elderly-patients
#23
JOURNAL ARTICLE
Hon-Chi Lee, Kristin Tl Huang, Win-Kuang Shen
Human aging is a global issue with important implications for current and future incidence and prevalence of health conditions and disability. Cardiac arrhythmias, including atrial fibrillation, sudden cardiac death, and bradycardia requiring pacemaker placement, all increase exponentially after the age of 60. It is important to distinguish between the normal, physiological consequences of aging on cardiac electrophysiology and the abnormal, pathological alterations. The age-related cardiac changes include ventricular hypertrophy, senile amyloidosis, cardiac valvular degenerative changes and annular calcification, fibrous infiltration of the conduction system, and loss of natural pacemaker cells and these changes could have a profound effect on the development of arrhythmias...
September 2011: Journal of Geriatric Cardiology: JGC
https://read.qxmd.com/read/21812498/is-antiarrhythmic-treatment-in-the-elderly-different-a-review-of-the-specific-changes
#24
REVIEW
Vera H M Deneer, Norbert M van Hemel
Aging is associated with electrical and structural changes of the myocardium. The response to catecholamines is also reduced and the baroreceptor reflex activity is blunted. These aspects conceivably affect the response to antiarrhythmic drugs in the elderly. Furthermore, physiological parameters change in older age, affecting the pharmacokinetics of drugs. In this article, the literature on the pharmacokinetics and pharmacodynamics of antiarrhythmic drugs in elderly subjects is reviewed with the purpose of improving their optimal and safe prescription...
August 1, 2011: Drugs & Aging
https://read.qxmd.com/read/26345308/statins-for-primary-cardiovascular-prevention-in-the-elderly
#25
REVIEW
Juan Pedro-Botet, Elisenda Climent, Juan J Chillarón, Rocio Toro, David Benaiges, Juana A Flores-Le Roux
The elderly population is increasing worldwide, with subjects > 65 years of age constituting the fastest-growing age group. Furthermore, the elderly face the greatest risk and burden of cardiovascular disease mortality and morbidity. Although elderly patients, particularly those older > 75, have not been well represented in randomized clinical trials evaluating lipid-lowering therapy, the available evidence supporting the use of statin therapy in primary prevention in older individuals is derived mainly from subgroup analyses and post-hoc data...
July 2015: Journal of Geriatric Cardiology: JGC
https://read.qxmd.com/read/21795660/a-randomized-double-blind-placebo-controlled-trial-of-simvastatin-to-treat-alzheimer-disease
#26
RANDOMIZED CONTROLLED TRIAL
M Sano, K L Bell, D Galasko, J E Galvin, R G Thomas, C H van Dyck, P S Aisen
BACKGROUND: Lowering cholesterol is associated with reduced CNS amyloid deposition and increased dietary cholesterol increases amyloid accumulation in animal studies. Epidemiologic data suggest that use of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) may decrease the risk of Alzheimer disease (AD) and a single-site trial suggested possible benefit in cognition with statin treatment in AD, supporting the hypothesis that statin therapy is useful in the treatment of AD...
August 9, 2011: Neurology
https://read.qxmd.com/read/21748738/geriatric-assessment-tools
#27
REVIEW
Sonja L Rosen, David B Reuben
In addition to medical diseases, psychological, social, cognitive, and functional issues influence the health of older persons. Therefore, the traditional medical assessment alone is often not enough to evaluate the older population with multiple comorbidities. Out of this recognized need, the geriatric assessment has been developed, which emphasizes a broader approach to evaluating contributors to health in older persons. Geriatric assessment uses specific tools to help determine patient's status across several different dimensions, including assessment of medical, cognitive, affective, social, economic, environmental, spiritual, and functional status...
2011: Mount Sinai Journal of Medicine, New York
https://read.qxmd.com/read/20048028/myelodysplastic-syndromes-a-practical-approach-to-diagnosis-and-treatment
#28
REVIEW
Afsaneh Barzi, Mikkael A Sekeres
The myelodysplastic syndromes (MDS) are clonal bone marrow disorders that lead to underproduction of normal blood cells. The consequent cytopenias result in infections and bleeding complications. MDS transform to acute myeloid leukemia in one-third of patients. The number of diagnoses has exploded in the past decade as a result of increased recognition and understanding of the disease and the aging of the population. New therapies can extend life. MDS are now considered the most common form of leukemia, and in some cases deserve immediate intervention...
January 2010: Cleveland Clinic Journal of Medicine
https://read.qxmd.com/read/19347026/delirium-in-elderly-adults-diagnosis-prevention-and-treatment
#29
REVIEW
Tamara G Fong, Samir R Tulebaev, Sharon K Inouye
Delirium is a common and serious acute neuropsychiatric syndrome with core features of inattention and global cognitive dysfunction. The etiologies of delirium are diverse and multifactorial and often reflect the pathophysiological consequences of an acute medical illness, medical complication or drug intoxication. Delirium can have a widely variable presentation, and is often missed and underdiagnosed as a result. At present, the diagnosis of delirium is clinically based and depends on the presence or absence of certain features...
April 2009: Nature Reviews. Neurology
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.